One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-123930
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 17 |
Affiliation: Medical University of Vienna, AbbVie (United States), Medical University of Lodz, Copernicus Memorial Hospital, University of Calgary, Jewish General Hospital, Hospital Universitario 12 De Octubre, University Hospital of Montpellier, Australian National University, Roche (United Kingdom), St James's University Hospital, Columbia University Irving Medical Center, University of Amsterdam, Hovon, University Hospital Cologne, University of Cologne, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Melbourne, Ospedale Niguarda Ca' GrandaFour-Year Analysis of Murano Study Confirms Sustained Benefit of Time-Limited Venetoclax-Rituximab (VenR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
